The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis

Martina Veith,1 Julia Tüffers,1 Erika Peychev,1 Andreas Klemmer,1 Viktor Kotke,1 Sabina Janciauskiene,2 Susanne Wilhelm,1 Robert Bals,3 Andreas Rembert Koczulla,4 Claus Franz Vogelmeier,1 Timm Greulich1 1Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center...

Full description

Bibliographic Details
Main Authors: Veith M, Tüffers J, Peychev E, Klemmer A, Kotke V, Janciauskiene S, Wilhelm S, Bals R, Koczulla AR, Vogelmeier CF, Greulich T
Format: Article
Language:English
Published: Dove Medical Press 2020-11-01
Series:International Journal of COPD
Subjects:
Online Access:https://www.dovepress.com/the-distribution-of-alpha-1-antitrypsin-genotypes-between-patients-wit-peer-reviewed-article-COPD
_version_ 1819213412735909888
author Veith M
Tüffers J
Peychev E
Klemmer A
Kotke V
Janciauskiene S
Wilhelm S
Bals R
Koczulla AR
Vogelmeier CF
Greulich T
author_facet Veith M
Tüffers J
Peychev E
Klemmer A
Kotke V
Janciauskiene S
Wilhelm S
Bals R
Koczulla AR
Vogelmeier CF
Greulich T
author_sort Veith M
collection DOAJ
description Martina Veith,1 Julia Tüffers,1 Erika Peychev,1 Andreas Klemmer,1 Viktor Kotke,1 Sabina Janciauskiene,2 Susanne Wilhelm,1 Robert Bals,3 Andreas Rembert Koczulla,4 Claus Franz Vogelmeier,1 Timm Greulich1 1Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Member of the German Center for Lung Research, Marburg, Germany; 2Clinic for Pneumology, German Center for Lung Research (DZL), Medical University Hannover, Hannover, Germany; 3Department of Internal Medicine V, Pulmonology, Allergology, Respiratory and Intensive Care Medicine, Saarland Hospital, Homburg/Saar, Germany; 4Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Teaching Hospital of Philipps-University of Marburg, Marburg, GermanyCorrespondence: Martina VeithDepartment of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Member of the German Center for Lung Research, Marburg, GermanyTel +4964215864723Fax +496421586370Email veithm@staff.uni-marburg.dePurpose: Alpha-1-antitrypsin deficiency (AATD) is a rare hereditary condition characterized by low circulating levels of alpha-1antitrypsin (AAT). While the association between AATD and COPD/emphysema is undisputed, the association between AATD and asthma or bronchiectasis is still a matter of debate.Aims and Objectives: Our study aimed to investigate the distribution of AAT genotypes between patients with COPD/emphysema, asthma and bronchiectasis. To back up the diagnostic labels, we described symptoms associated with the diagnosis.Methods: Between September 2003 and March 2020, 29,465 testing kits (AlphaKit®) were analyzed in the AAT laboratory, University of Marburg, Germany. The diagnosis of AATD has been made based on the measurements of AAT serum levels, followed by genotyping, phenotyping or whole gene sequencing depending on the availability and/or the need for more detailed interpretation of the results. The respiratory symptoms were recorded as well.Results: Regarding the distribution of the wild type allele M and the most frequent mutations S (E264V) and Z (E342K), no significant differences could be found between COPD/emphysema [Pi*MM (58.24%); Pi*SZ (2.49%); Pi*ZZ (9.12%)] and bronchiectasis [Pi*MM (59.30%) Pi*SZ (2.81%); Pi*ZZ (7.02%)]. When COPD/emphysema and bronchiectasis were recorded in the same patient, the rate of Pi* ZZ (14.78%) mutations was even higher. Asthma patients exhibited significantly less deficient genotypes [Pi*MM (54.81%); Pi*SZ (2%); Pi*ZZ (2.77%)] than two other groups. Associated respiratory symptoms confirmed the diagnosis.Conclusion: COPD/emphysema and bronchiectasis, but not asthma patients, exhibit higher frequency of AATD genotypes. Our data suggest that AATD testing should be offered to patients with COPD/emphysema and bronchiectasis.Keywords: SERPINA1, alpha-1-antitrypsin deficiency, bronchiectasis, asthma, diagnosis
first_indexed 2024-12-23T06:58:27Z
format Article
id doaj.art-6cafa05bac924c9692b9348effbf2275
institution Directory Open Access Journal
issn 1178-2005
language English
last_indexed 2024-12-23T06:58:27Z
publishDate 2020-11-01
publisher Dove Medical Press
record_format Article
series International Journal of COPD
spelling doaj.art-6cafa05bac924c9692b9348effbf22752022-12-21T17:56:14ZengDove Medical PressInternational Journal of COPD1178-20052020-11-01Volume 152827283659023The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and BronchiectasisVeith MTüffers JPeychev EKlemmer AKotke VJanciauskiene SWilhelm SBals RKoczulla ARVogelmeier CFGreulich TMartina Veith,1 Julia Tüffers,1 Erika Peychev,1 Andreas Klemmer,1 Viktor Kotke,1 Sabina Janciauskiene,2 Susanne Wilhelm,1 Robert Bals,3 Andreas Rembert Koczulla,4 Claus Franz Vogelmeier,1 Timm Greulich1 1Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Member of the German Center for Lung Research, Marburg, Germany; 2Clinic for Pneumology, German Center for Lung Research (DZL), Medical University Hannover, Hannover, Germany; 3Department of Internal Medicine V, Pulmonology, Allergology, Respiratory and Intensive Care Medicine, Saarland Hospital, Homburg/Saar, Germany; 4Institute for Pulmonary Rehabilitation Research, Schoen Klinik Berchtesgadener Land, Teaching Hospital of Philipps-University of Marburg, Marburg, GermanyCorrespondence: Martina VeithDepartment of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Member of the German Center for Lung Research, Marburg, GermanyTel +4964215864723Fax +496421586370Email veithm@staff.uni-marburg.dePurpose: Alpha-1-antitrypsin deficiency (AATD) is a rare hereditary condition characterized by low circulating levels of alpha-1antitrypsin (AAT). While the association between AATD and COPD/emphysema is undisputed, the association between AATD and asthma or bronchiectasis is still a matter of debate.Aims and Objectives: Our study aimed to investigate the distribution of AAT genotypes between patients with COPD/emphysema, asthma and bronchiectasis. To back up the diagnostic labels, we described symptoms associated with the diagnosis.Methods: Between September 2003 and March 2020, 29,465 testing kits (AlphaKit®) were analyzed in the AAT laboratory, University of Marburg, Germany. The diagnosis of AATD has been made based on the measurements of AAT serum levels, followed by genotyping, phenotyping or whole gene sequencing depending on the availability and/or the need for more detailed interpretation of the results. The respiratory symptoms were recorded as well.Results: Regarding the distribution of the wild type allele M and the most frequent mutations S (E264V) and Z (E342K), no significant differences could be found between COPD/emphysema [Pi*MM (58.24%); Pi*SZ (2.49%); Pi*ZZ (9.12%)] and bronchiectasis [Pi*MM (59.30%) Pi*SZ (2.81%); Pi*ZZ (7.02%)]. When COPD/emphysema and bronchiectasis were recorded in the same patient, the rate of Pi* ZZ (14.78%) mutations was even higher. Asthma patients exhibited significantly less deficient genotypes [Pi*MM (54.81%); Pi*SZ (2%); Pi*ZZ (2.77%)] than two other groups. Associated respiratory symptoms confirmed the diagnosis.Conclusion: COPD/emphysema and bronchiectasis, but not asthma patients, exhibit higher frequency of AATD genotypes. Our data suggest that AATD testing should be offered to patients with COPD/emphysema and bronchiectasis.Keywords: SERPINA1, alpha-1-antitrypsin deficiency, bronchiectasis, asthma, diagnosishttps://www.dovepress.com/the-distribution-of-alpha-1-antitrypsin-genotypes-between-patients-wit-peer-reviewed-article-COPDserpina1alpha-1-antitrypsin deficiencybronchiectasisasthmadiagnosis
spellingShingle Veith M
Tüffers J
Peychev E
Klemmer A
Kotke V
Janciauskiene S
Wilhelm S
Bals R
Koczulla AR
Vogelmeier CF
Greulich T
The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
International Journal of COPD
serpina1
alpha-1-antitrypsin deficiency
bronchiectasis
asthma
diagnosis
title The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
title_full The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
title_fullStr The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
title_full_unstemmed The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
title_short The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
title_sort distribution of alpha 1 antitrypsin genotypes between patients with copd emphysema asthma and bronchiectasis
topic serpina1
alpha-1-antitrypsin deficiency
bronchiectasis
asthma
diagnosis
url https://www.dovepress.com/the-distribution-of-alpha-1-antitrypsin-genotypes-between-patients-wit-peer-reviewed-article-COPD
work_keys_str_mv AT veithm thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT tuffersj thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT peycheve thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT klemmera thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT kotkev thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT janciauskienes thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT wilhelms thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT balsr thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT koczullaar thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT vogelmeiercf thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT greulicht thedistributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT veithm distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT tuffersj distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT peycheve distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT klemmera distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT kotkev distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT janciauskienes distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT wilhelms distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT balsr distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT koczullaar distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT vogelmeiercf distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis
AT greulicht distributionofalpha1antitrypsingenotypesbetweenpatientswithcopdemphysemaasthmaandbronchiectasis